Chandni Anand, MD
Internal Medicine · Minot, NDNPI 1518908862
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Novo Nordisk at 27.7% of the total. 2025 is the largest year on record at $1,016, more than ten times the $85 reported in 2019. Among internal medicine clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 126 payments — averaging $20.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$705
- AstraZeneca$311
- Lilly USA, LLC$273
- GSK$250
- Amgen$246
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$114
- plus $647 from 19 others
What the payments were for
- Food & beverage$2,546100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 37 | $705 |
| AstraZeneca | 8 | $311 |
| Lilly USA, LLC | 15 | $273 |
| GSK | 13 | $250 |
| Amgen | 14 | $246 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $114 |
| Astellas Pharma US Inc | 3 | $89 |
| Pfizer | 4 | $80 |
| Bayer | 4 | $63 |
| Exact Sciences | 4 | $63 |
| Boston Scientific | 2 | $47 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Medtronic | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Itamar Medical Inc | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| AbbVie | 1 | $23 |
| Almatica Pharma LLC | 1 | $20 |
| Abbott | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $16 |
| Intra-sana Laboratories | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$120
How this compares
$2,546 in reported general payments places this provider in the 90th percentile of 159 internal medicine providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 18 | $20,614 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $4,562 |
| Pantoprazole Sodium | 28 | $656 |
| SynthroidLevothyroxine Sodium | 20 | $528 |
| Levothyroxine Sodium | 66 | $474 |
| Losartan Potassium | 41 | $448 |
| Rosuvastatin Calcium | 38 | $405 |
| Ipratropium Bromide | 13 | $405 |
| Olmesartan Medoxomil | 11 | $403 |
| Atorvastatin Calcium | 56 | $401 |
| Metformin Hcl | 23 | $389 |
| Lisinopril | 76 | $359 |
| Amlodipine Besylate | 75 | $279 |
| Sertraline Hcl | 20 | $233 |
| Gabapentin | 30 | $213 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $273 | $20,61418 claims |
| GSKBreo Ellipta | $250 | $4,56212 claims |
| AbbVieSynthroid | $23 | $52820 claims |
| Almatica Pharma LLCSertraline Hcl | $20 | $23320 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 159 internal medicine providers in North Dakota.
Other internal medicine in Minot
- Steven MattsonMinot$990
- Roggie ReasonMinot$276
- Michael LillestolFargo$18K
- Khalin DendyBismarck$10K
- Bruce OlinDickinson$8K
- Gene SchwartzTrenton$6K
- Stephanie CanhamBismarck$4K
- Radu RautaBismarck$3K
- Donald GrenzBismarck$3K
- Julia SchwartzBismarck$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.